BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 35413679)

  • 1. A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets in Uterine Corpus Endometrial cancer.
    Lei P; Wang H; Yu L; Xu C; Sun H; Lyu Y; Li L; Zhang DL
    Int Immunopharmacol; 2022 Jul; 108():108743. PubMed ID: 35413679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors.
    Hamann J; Aust G; Araç D; Engel FB; Formstone C; Fredriksson R; Hall RA; Harty BL; Kirchhoff C; Knapp B; Krishnan A; Liebscher I; Lin HH; Martinelli DC; Monk KR; Peeters MC; Piao X; Prömel S; Schöneberg T; Schwartz TW; Singer K; Stacey M; Ushkaryov YA; Vallon M; Wolfrum U; Wright MW; Xu L; Langenhan T; Schiöth HB
    Pharmacol Rev; 2015; 67(2):338-67. PubMed ID: 25713288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets for breast cancer.
    Shi W; Xu C; Lei P; Sun X; Song M; Guo Y; Song W; Li Y; Yu L; Zhang H; Wang H; Zhang DL
    Breast Cancer Res Treat; 2024 Jun; ():. PubMed ID: 38834774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNF183 Is a Prognostic Biomarker and Correlates With Tumor Purity, Immune Infiltrates in Uterine Corpus Endometrial Carcinoma.
    Geng R; Zheng Y; Zhao L; Huang X; Qiang R; Zhang R; Guo X; Li R
    Front Genet; 2020; 11():595733. PubMed ID: 33324448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets.
    Liu F; Wu H
    J Inflamm Res; 2021; 14():267-285. PubMed ID: 33574689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KDM4B, a potential prognostic biomarker revealed by large-scale public databases and clinical samples in uterine corpus endometrial carcinoma.
    Zhang M; Liu Y; Hou S; Wang Y; Wang C; Yin Y; Chen X
    Mol Omics; 2022 Jul; 18(6):506-519. PubMed ID: 35485290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of the ferroptosis-associated MGST1 gene in relation to poor outcome and maladjusted immune cell infiltration in uterine corpus endometrial carcinoma.
    Yan J; Ye G; Shao Y
    J Clin Lab Anal; 2022 Apr; 36(4):e24317. PubMed ID: 35218676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma.
    Wang G; Fu J; Liu M; Zheng Q
    PLoS One; 2024; 19(1):e0277872. PubMed ID: 38232115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Circadian Gene NPAS2 Act as a Putative Tumor Stimulative Factor for Uterine Corpus Endometrial Carcinoma.
    Zheng X; Lv X; Zhu L; Xu K; Shi C; Cui L; Ding H
    Cancer Manag Res; 2021; 13():9329-9343. PubMed ID: 34992456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of N-7 methylguanine-related mRNA prognostic model in uterine corpus endometrial carcinoma based on multi-omics data and immune-related analysis.
    Zhao J; Zou J; Jiao W; Lin L; Wang J; Lin Z
    Sci Rep; 2022 Nov; 12(1):18813. PubMed ID: 36335189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dysregulation of MAD2L1/CAMK2A/PTTG1 Gene Cluster Maintains the Stemness Characteristics of Uterine Corpus Endometrial Carcinoma].
    Zheng J; Zhang YW; Pan ZF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Oct; 43(5):685-695. PubMed ID: 34728029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal transducer and activator of transcription family is a prognostic marker associated with immune infiltration in endometrial cancer.
    Zhou XY; Dai HY; Zhang H; Zhu JL; Hu H
    J Clin Lab Anal; 2022 Apr; 36(4):e24315. PubMed ID: 35244291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Signatures and Prognostic Value of m6A RNA Methylation Regulators in Uterine Corpus Endometrial Carcinoma.
    Feng Y; Yao C; Shen J; Zhou J
    Discov Med; 2021; 31(164):111-120. PubMed ID: 35188885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 14-Methylation-Driven Differentially Expressed RNA as a Signature for Overall Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.
    Zeng Z; Cheng J; Ye Q; Zhang Y; Shen X; Cai J; Li M
    DNA Cell Biol; 2020 Jun; 39(6):975-991. PubMed ID: 32397815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide characterization of aberrant DNA methylation patterns and the potential clinical implications in patients with endometrial cancer.
    Wang Y; Liu D; Jin X; Song H; Lou G
    Pathol Res Pract; 2019 Jan; 215(1):137-143. PubMed ID: 30449607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a six-gene signature with prognostic value for patients with endometrial carcinoma.
    Wang Y; Ren F; Chen P; Liu S; Song Z; Ma X
    Cancer Med; 2018 Nov; 7(11):5632-5642. PubMed ID: 30306731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance analysis of PAX8 expression in endometrial carcinoma.
    Hu S; Gan H; Yang F
    Medicine (Baltimore); 2022 Oct; 101(42):e31159. PubMed ID: 36281161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LAMP3 is a potent uterine corpus endometrial carcinoma prognostic biomarker associated with immune behavior.
    Fu B; Zhou M; Geng X; Jiang Y; Zeng H; Zhou X; Yu Z; Pan J; Zhu Y; Zheng H; Huang S; Gong Y; Huang D; Zhong Y
    Aging (Albany NY); 2024 Jan; 16(1):714-745. PubMed ID: 38217544
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Zhao Q; Chen G; Yang X; Wang T; Yuan S; Meng Q
    Comb Chem High Throughput Screen; 2023; 26(2):330-338. PubMed ID: 35379118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Prognostic Biomarkers and Molecular Targets Among JAK Family in Breast Cancer.
    Liu F; Wu H
    J Inflamm Res; 2021; 14():97-114. PubMed ID: 33469338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.